Qingdao is the first to follow up the national catalogue

Recently, Qingdao Municipal Hospital issued "Temporary Catalogue of Key Supervision Drugs in Hospitals", "Catalogue of Traditional Chinese Medicine Injections in Hospitals" and "Limit Indicators of the Total Monthly Use Amount of Key Supervision Drugs in Departments". Recently, Qingdao Municipal Hospital issued the Circular of "Implementing Opinions on Further Strengthening the Management of Clinical Rational Drug Use", issued the Temporary Catalogue of Key Monitoring Drugs in Hospital, the Catalogue of Traditional Chinese Medicine Injections in Hospital and the Index of the Limit of the Total Monthly Use Amount of Key Monitoring Drugs in Departments and Departments. Detailed regulations are made on the supervision and control of medicines, pieces of traditional Chinese medicines and the authority management of prescriptions of Chinese patent medicines.
Qingdao took the Lead in following up the national catalogue, and issued the "temporary catalogue of key controlled drugs in hospitals". Opinions pointed out that according to the first batch of national key controlled drugs catalogue and the catalogue of key controlled drugs in Qingdao, the provisional catalogue of key controlled drugs in hospitals should be formulated. It will be adjusted after Shandong Provincial Health Commission publishes the list of key controlled drugs in Shandong Province. Among them, 36 generic names were included, which not only covered 17 national editions of key controlled drugs (compound coenzyme, Ribonucleic acid, calf blood deproteinized extract not included), but also included Xuesaitong, Xueshuantong, Guhong and other traditional Chinese medicine injection varieties.
Strengthen the administration of traditional Chinese medicine injections, and issue the first "Hospital Catalogue of Traditional Chinese Medicine Injections". Opinions"to implement the authority management of prescriptions of Chinese patent medicine and Chinese medicine Pieces in accordance with the document requirements of the State Health Commission. Consistent with the provisions of the national version of the catalogue of key monitoring and rational drug use, Qingdao Municipal Hospital has prescription authority only for TCM physicians; other types of licensed physicians can grant prescription rights for TCM tablets and injections only if they meet the requirements of training and assessment stipulated by the state.
For the administration of traditional Chinese medicine injections, Opinions published the first batch of Catalogues of Traditional Chinese Medicine Injections in Hospital, 32 varieties of Compound Sophora Flavescens Injection, Shenqi Fuzheng Injection and Brucea javanica Oil Emulsion were listed. Limited indicators. Real-time monitoring and early warning are carried out for key departments to monitor the amount of drugs used, and the performance of doctors in departments exceeding the limit is deducted according to the amount exceeding the limit. The Drug Supply Section formulates the procurement plan according to the quota indicators of the total monthly amount of the key monitored drugs, and the Ministry of Pharmacy distributes them according to the quota indicators of each department. Reduce the average drug cost of hospitalization; adjust the assessment method for the increase of average drug cost of hospitalization. The increase rate of average drug cost of hospitalization is the comparison of average drug cost of each discharged patient with the same period of last year. If the average drug cost of departments increases year on year, the increase rate should be multiplied by the increase of average drug cost and discharged disease. Direct deduction of doctor performance. The State Health and Health Commission officially issued a statistical bulletin on the development of China's health care in 2018, which showed that the per capita hospital drug expenditure has dropped to 28.2%, or less than 30%. For the first time, the proportion of hospitalized drug expenses in township hospitals has dropped below 40%. Although the proportion of drugs in tertiary public hospitals is no longer included in the evaluation index in 2019, it requires that the overall cost be basically flat. After the implementation of many policies, such as banning the injection of Antibiotics in outpatient clinics and restricting the use of auxiliary drugs, it is expected that the proportion of drugs still has room to decline.
2026-07-25
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Maximum reduction of 81%! 22,000 down to $6,300 Large group of consumables with collective price cuts
-
Overview of China's medical device import and export trade in 2021
-
5 Billion! Strong Growth! Top 1 Sample Hospital Variety
-
Do You Know the Real Benefits of Eating Bird's Nest?
-
Polycarbonate PC turns out to have so many uses
-
Nation helping meet global demand for medical supplies
-
Prohibited, restricted production, sale and use of plastic products
-
Yanan Petrochemical converted polypropylene medical non-woven fabric material
-
Medicare Payment: Grass-roots co-ordinated payment
-
Xinlitai heavy new product will be approved soon
Recommend Reading
-
Clean Food Group Secures UK, EU, and US Approval for Fermentation-Derived Cosmetic Oils
-
Trinseo Faces Pressure in Resin Markets but Sees Growth in Recycled Products
-
Chevron Opens Oilfield Chemical Technology to Rivals
-
Bridgestone Reports Q3 Growth Amid Challenging North American Market
-
Middle East Conflict Exposes Fragility of Global Fertilizer Supply Chains
-
MTBE Market Trend Consolidates Weakly
-
This Week's Epichlorohydrin Market Transaction Focus Shifted Upward and Stabilized (11.10-11.14)
-
This week, the cyclohexane market in China showed a weak trend (9.19-9.26)
-
South Korea Expands Mandatory GMO Labeling to Highly Processed Foods
-
This Week, the Transaction Focus of China's Propylene Oxide Market Rises (11.10-11.14)